Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.07	9.17	17.95	5.09	24.57	38.45
Short-Term Investments	18.52	0.3	48.82	108.1	226.04	-
Cash & Short-Term Investments	21.58	9.48	66.77	113.19	250.61	38.45
Cash Growth	80.53%	-85.81%	-41.01%	-54.84%	551.80%	122.10%
Accounts Receivable	4.53	4.75	9.32	7.02	4.93	2.78
Other Receivables	-	0.02	0.34	0.47	-	-
Receivables	4.53	4.77	9.66	7.5	4.93	2.78
Inventory	7.05	11.12	22.89	29.76	12.39	3.32
Prepaid Expenses	5.38	0.7	1.1	1.39	4.48	0.64
Other Current Assets	10.27	13.42	39.69	5.47	-	1.61
Total Current Assets	48.8	39.49	140.12	157.3	272.41	46.79
Property, Plant & Equipment	22.82	24.32	32.48	28.96	20.94	4.91
Goodwill	-	-	-	77.29	56.16	7.17
Other Intangible Assets	5.69	9.71	33.97	41.14	26.84	1.48
Other Long-Term Assets	1.76	3.15	7.83	2.81	0.75	0.1
Total Assets	79.06	76.67	214.4	307.5	377.1	60.45
Accounts Payable	5.99	6.96	10.38	12.53	10.77	2.93
Accrued Expenses	3.7	4.62	6.58	9.22	6.94	4.36
Short-Term Debt	9.83	20.36	69.8	-	-	-
Current Portion of Leases	1.28	3.25	2.44	2.55	1.77	-
Current Income Taxes Payable	0.48	0.73	1.1	0.83	0.68	0.56
Current Unearned Revenue	1.18	1.13	0.78	0.87	0.68	0.42
Other Current Liabilities	0.53	0.29	8.94	9.89	1	0.68
Total Current Liabilities	22.98	37.34	100.03	35.88	21.84	8.95
Long-Term Debt	-	-	-	-	-	16.33
Long-Term Leases	6.09	3.68	7.18	9.12	8.93	-
Long-Term Unearned Revenue	0.19	0.27	0.15	0.13	0.15	0.1
Other Long-Term Liabilities	-	-	10.89	12.97	9.07	-
Total Liabilities	29.26	41.3	118.25	58.1	39.98	25.37
Common Stock	0	-	-	0	0.03	0.02
Additional Paid-In Capital	761.48	728.57	677.34	599.23	553.75	178.75
Retained Earnings	-711.69	-693.23	-581.21	-348.72	-216.12	-143.68
Comprehensive Income & Other	0.01	0.03	0.02	-1.12	-0.54	-
Total Common Equity	49.8	35.38	96.16	249.4	337.12	35.08
Shareholders' Equity	49.8	35.38	96.16	249.4	337.12	35.08
Total Liabilities & Equity	79.06	76.67	214.4	307.5	377.1	60.45
Total Debt	17.2	27.3	79.41	11.67	10.7	16.33
Net Cash (Debt)	4.39	-17.82	-12.64	101.52	239.92	22.12
Net Cash Growth	-	-	-	-57.69%	984.42%	-
Net Cash Per Share	1.34	-14.02	-22.22	210.61	520.08	127.33
Filing Date Shares Outstanding	10.18	3.01	0.91	0.51	0.48	0.46
Total Common Shares Outstanding	9.73	1.87	0.76	0.5	0.48	0.32
Working Capital	25.82	2.15	40.09	121.41	250.57	37.84
Book Value Per Share	5.12	18.96	126.10	503.52	698.44	110.81
Tangible Book Value	44.11	25.67	62.18	130.97	254.12	26.43
Tangible Book Value Per Share	4.53	13.76	81.55	264.41	526.48	83.50
Machinery	-	42.76	38.68	27.11	16.72	10.48
Leasehold Improvements	-	3.33	3.75	4	2.67	1.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.